Lycia Therapeutics, Inc. (NASDAQ:LYCA) IPO

Lycia Therapeutics, Inc.

IPO

Priced at US$18.00 a share on Oct 22, 2026.

Price
US$18.00 a share
Shares offered
17,640,000 shares of common stock
Offering size
US$317.5 million
Underwriters' option
Up to 2,646,000 more shares
Listing
LYCA on the Nasdaq Global Select Market
Underwriters
Jefferies, TD Cowen, Evercore ISI, Guggenheim Securities, LifeSci Capital · In the order on the cover
Shares delivered
On or about Oct 26, 2026

Steps

StepWhen
Draft sent to the SEC in confidenceJul 2, 2026
Filed publiclyOct 5, 2026
Amended onceOct 20, 2026
Shares registered with an exchangeOct 20, 2026
Declared effective by the SECOct 22, 2026
Final prospectus, with the priceOct 23, 2026

From the cover of the final prospectus (424B4) filed Oct 23, 2026